Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS >= 1% | AVESİS

Istanbul University Research Information System

Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS >= 1%

Copy For Citation

Lopes G., Wu Y., Kudaba I., Kowalski D., Cho B., Turna H., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.13, no.9, 2018 (SCI-Expanded)

Publication Type: Article / Abstract
Volume: 13 Issue: 9
Publication Date: 2018
Doi Number: 10.1016/j.jtho.2018.07.020
Journal Name: JOURNAL OF THORACIC ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Istanbul University Affiliated: Yes